Identity
What is NAD+?
The oxidized form of nicotinamide adenine dinucleotide (also called nadide).

Research reference · Cellular Energy
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme in cellular energy and redox reactions, not a peptide. Most human research tests its precursors, NR and NMN.
Published by Elevated Pharma ·
Identity
The oxidized form of nicotinamide adenine dinucleotide (also called nadide).
Research context
Human randomized trials of NR and NMN measure blood NAD+ and metabolic markers. A 2026 Nature Metabolism study compared three precursors head to head.
Evidence boundary
Raising blood NAD+ is not the same as a clinical benefit, and precursor studies do not describe NAD+ itself given directly.
U.S. status · November 7, 2026
No therapeutic or approved-product claim is made.
A randomized study in 65 adults found NR and NMN raised blood NAD+ over 14 days while nicotinamide did not.
Read the sourceKey studies
Selected from PubMed: human trials first, then reviews, then foundational laboratory work. Each finding applies to the material and setting studied.
Search all PubMed records for NAD+ · Counts and selections checked November 7, 2026.
Reference identifiers
Database identity describes the reference substance, not any specific material or lot.
Official & primary sources
Citation does not imply an Elevated Pharma partnership or endorsement.